Adicet Bio Inc (ACET)
2.18
+0.18
(+9.00%)
USD |
NASDAQ |
Apr 23, 10:11
Adicet Bio Shareholders Equity (Quarterly): 170.18M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 170.18M |
| September 30, 2023 | 194.68M |
| June 30, 2023 | 239.06M |
| March 31, 2023 | 266.22M |
| December 31, 2022 | 292.34M |
| September 30, 2022 | 317.66M |
| June 30, 2022 | 293.27M |
| March 31, 2022 | 311.08M |
| Date | Value |
|---|---|
| December 31, 2021 | 303.13M |
| September 30, 2021 | 217.22M |
| June 30, 2021 | 228.34M |
| March 31, 2021 | 236.26M |
| December 31, 2020 | 109.83M |
| September 30, 2020 | 116.93M |
| December 31, 2019 | -60.37M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-60.37M
Minimum
Dec 2019
317.66M
Maximum
Sep 2022
215.72M
Average
236.26M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Sagimet Biosciences Inc | 91.06M |
| Catalyst Pharmaceuticals Inc | 387.88M |
| Codexis Inc | 86.62M |
| Annexon Inc | 250.56M |
| Inhibrx Inc | 43.50M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 207.30M |
| Total Liabilities (Quarterly) | 37.12M |